12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Human neural stem cells: Phase I/II started

StemCells began an open-label, dose-escalation, U.S. Phase I/II trial to evaluate intraocular HuCNS-SC in about 16 patients with dry AMD. The product...

Read the full 88 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >